Cargando…
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of several unmet medical needs, including acute lung injury/acute respiratory distress syndrome (ALI/ARDS) wherein siRNA may be implemented to modify the expression of pro-inflammatory cytokines and chemokines...
Autores principales: | Zoulikha, Makhloufi, Xiao, Qingqing, Boafo, George Frimpong, Sallam, Marwa A., Chen, Zhongjian, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359643/ https://www.ncbi.nlm.nih.gov/pubmed/34401226 http://dx.doi.org/10.1016/j.apsb.2021.08.009 |
Ejemplares similares
-
Pulmonary delivery of therapeutic siRNA
por: Lam, Jenny Ka-Wing, et al.
Publicado: (2012) -
Pulmonary drug delivery for acute respiratory distress syndrome
por: Fei, Qinqin, et al.
Publicado: (2023) -
COVID-19 inflammation and implications in drug delivery
por: Zoulikha, Makhloufi, et al.
Publicado: (2022) -
Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006) -
Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)